A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Arthritis & Rheumatism

Topics

Medicine

Internal Medicine

Pediatrics

Hematology

Surgery

Show all topics

DOI

10.1002/art.20288